Clinical Trials Logo

Clinical Trial Summary

The aim is to expand evidence about the importance of the mediodorsal nucleus of the thalamus as a key node in human higher-order cognitive functions such as learning, decision-making, and adaptive behavior. Thus, the project proposes to assess global cognition along with higher-order cognition integrity via sensitive behavior tasks in patients with well localized lesions (mediodorsal thalamic infarcts) compared with healthy participants.


Clinical Trial Description

The recruitment of patients with isolated thalamic lesion after stroke is known to be a challenge that the investigators overcame through the expertise of neurologists within their stroke unit.

First, they will describe the cognitive profile consecutive to a lesion of the thalamus, assessed with standardized neuropsychological tests.

Second, and more specifically, they will study performances at experimental tasks focusing on higher-order cognition (decision-making, updating, interference managing, multitasking).

They will use the automatic localization method already performed : the lesions will be manually segmented from T1 morphologic sequences, and then normalized in a template. Finally a numerical atlas of thalamus will be applied on the lesions, determining the injured substructure and the lesion volume.

Besides, this method will be compared with new high resolution thalamus-centered anatomical sequences allowing direct and individual identification of the involved thalamic nucleus. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03867149
Study type Interventional
Source University Hospital, Toulouse
Contact Jérémie PARIENTE, MD, PHD
Phone 05 61 77 76 86
Email jeremie.pariente@inserm.fr
Status Recruiting
Phase N/A
Start date May 14, 2019
Completion date April 2023

See also
  Status Clinical Trial Phase
Completed NCT04921683 - The Use of LIFUP in Chronic Disorders of Consciousness N/A